← Eichor
Study identifier: NCT06042803 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

UmbrelLACT Study: Clinical Lactation Study on the Exposure to Medicines Via Human Milk

Condition: Breast Feeding · Human Milk  ·  Sponsor: Universitaire Ziekenhuizen KU Leuven

PhaseN/A
Planned participants30
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersYes

About this study

The goal of this observational study is to determine the concentration of medicines in human milk during maternal medicine intake. The main questions it aims to answer are: * What is the concentration of maternal medicines in human milk? * What is the (estimated) intake and exposure in the breastfed infant? Participants will be asked to * fill out a questionnaire regarding medical data of the mother and child * track medication intake for 3 days * collect milk samples during 24 hours * optionally, donate 2 blood samples of the mother and give consent to one blood sample of the child * fill out a questionnaire regarding the general health of the child.

This description comes directly from the study's public registry record.

Talk to the study team

Anne Smits, MD, PhD  ·  +3216343565  ·  anne.smits@uzleuven.be

Martje Van Neste, MD  ·  +32 16 32 82 06  ·  martje.vanneste@kuleuven.be

Always discuss trial participation with your own doctor first.

Locations (1)

Universitaire Ziekenhuizen KU LeuvenLeuven, Vlaams-Brabant, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06042803